UNSPSC 85891921: Beam radiation of head and neck using heavy particles (protons,ions)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of beam radiation of head and neck using heavy particles (protons,ions)beam radiation of head and neck using heavy particles (protons, ions). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DW014ZZ

UNSPSC 85891921 Beam radiation of head and neck using heavy particles (protons, ions) is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The code's title references clinical radiation therapy, a highly specialized oncology service; however, the only recent opportunity posted under this code is the County of Santa Clara Health System's July 7, 2026 RFQ for temporary health professional staffing services across multiple ancillary clinical categories, due October 7, 2026. That solicitation encompasses Audiology, Cardiology and Vascular, Diagnostic Imaging/Radiology, Gastroenterology, Health Services Assistant, Medical Social Worker, Ophthalmology, Orthopedic, Patient Transporter, Respiratory Care, Sterile Processing, Surgical/Operating Room/Labor and Delivery, and Therapy Services — none of which align with proton or ion beam radiation therapy. The Health System explicitly excluded nursing, physician, and other non-clinical staffing, and this is a non-exclusive, multiple-award qualification vehicle with no guaranteed work.

The code shows minimal relevant recent activity. Santa Clara County's temporary staffing RFQ is the only posted opportunity; it does not represent demand for beam radiation services and appears to be a tagging error by the issuing body rather than genuine procurement demand under this code's actual scope. State and local buyers may rarely or not at all solicit proton or heavy-particle beam radiation therapy as a standalone service — such treatments are typically delivered in-house by hospital systems or specialized cancer centers with permanent infrastructure rather than through external procurement. Without additional opportunities posted under this code, visibility into actual buying patterns, repeat issuing bodies, or geographic concentration is not supported by the source.